Mitchel Jr Ruigrok

4PUBLICATIONS
14CO-AUTHORS
Medical infection agents (incl. prions)Predictive and prognostic markersGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 19, 2023
Targeted delivery of galunisertib using machine perfusion reduces fibrogenesis in an integrated ex vivo renal transplant and fibrogenesis model.

L Leonie van Leeuwen, Mitchel J R Ruigrok, Benedikt M Kessler

|Oct 27, 2022
Are inhaled mRNA vaccines safe and effective? A review of preclinical studies.

Evalyne M Jansen, Henderik W Frijlink, Wouter Lj Hinrichs

Pageof 1